A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

NCT06593522 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen